Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrizia Ferroni

Showing results (41-50 of 139) with videos related to

Pageof 14
Sort By:
Cardiovascular & Hematological Agents in Medicinal Chemistry|February 1, 2017
Anti-Angiogenic Drugs, Vascular Toxicity and Thromboembolism in Solid CancerSilvia Riondino, Girolamo Del Monte, Federica Fratangeli, et al.
Clinical Biochemistry|January 12, 2010
Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditionsSilvia Riondino, Francesca Martini, Francesca La Farina, et al.
In Vivo (Athens, Greece)|August 21, 2008
Interleukin-2 inhalation therapy in renal cell cancer: a case report and review of the literatureGirolamo Del Monte, Patrizia Ferroni, Sabrina Mariotti, et al.
Cancers|May 10, 2020
Venous Thromboembolism in Cancer Patients on Simultaneous and Palliative CareSilvia Riondino, Patrizia Ferroni, Girolamo Del Monte, et al.
Anticancer Research|November 1, 2007
Non-steroidal anti-inflammatory drugs in cancer prevention and therapyFiorella Guadagni, Patrizia Ferroni, Raffaele Palmirotta, et al.
Cancers|March 15, 2019
Breast Cancer Prognosis Using a Machine Learning ApproachPatrizia Ferroni, Fabio M Zanzotto, Silvia Riondino, et al.
Current Medicinal Chemistry|October 18, 2020
Irinotecan or Oxaliplatin: Which is the First Move for the Mate?Cristina Morelli, Vincenzo Formica, Silvia Riondino, et al.
Circulation|September 25, 2003
Enhanced interleukin-1beta in hypercholesterolemia: effects of simvastatin and low-dose aspirinPatrizia Ferroni, Francesca Martini, Cristiano M Cardarello, et al.
Current Vascular Pharmacology|May 9, 2013
Pleiotropic effects of PPARγ agonist on hemostatic activation in type 2 diabetes mellitusPatrizia Ferroni, David Della-Morte, Antonello Pileggi, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|March 3, 2012
Factor seven activating protease activity levels in women with recurrent pregnancy lossSilvia Riondino, Patrizia Ferroni, Francesca La Farina, et al.
Pageof 14

Showing results (41-50 of 139) with videos related to

Sort By:
Pageof 14
Cardiovascular & Hematological Agents in Medicinal Chemistry|February 1, 2017
Anti-Angiogenic Drugs, Vascular Toxicity and Thromboembolism in Solid CancerSilvia Riondino, Girolamo Del Monte, Federica Fratangeli, et al.
Clinical Biochemistry|January 12, 2010
Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditionsSilvia Riondino, Francesca Martini, Francesca La Farina, et al.
In Vivo (Athens, Greece)|August 21, 2008
Interleukin-2 inhalation therapy in renal cell cancer: a case report and review of the literatureGirolamo Del Monte, Patrizia Ferroni, Sabrina Mariotti, et al.
Cancers|May 10, 2020
Venous Thromboembolism in Cancer Patients on Simultaneous and Palliative CareSilvia Riondino, Patrizia Ferroni, Girolamo Del Monte, et al.
Anticancer Research|November 1, 2007
Non-steroidal anti-inflammatory drugs in cancer prevention and therapyFiorella Guadagni, Patrizia Ferroni, Raffaele Palmirotta, et al.
Cancers|March 15, 2019
Breast Cancer Prognosis Using a Machine Learning ApproachPatrizia Ferroni, Fabio M Zanzotto, Silvia Riondino, et al.
Current Medicinal Chemistry|October 18, 2020
Irinotecan or Oxaliplatin: Which is the First Move for the Mate?Cristina Morelli, Vincenzo Formica, Silvia Riondino, et al.
Circulation|September 25, 2003
Enhanced interleukin-1beta in hypercholesterolemia: effects of simvastatin and low-dose aspirinPatrizia Ferroni, Francesca Martini, Cristiano M Cardarello, et al.
Current Vascular Pharmacology|May 9, 2013
Pleiotropic effects of PPARγ agonist on hemostatic activation in type 2 diabetes mellitusPatrizia Ferroni, David Della-Morte, Antonello Pileggi, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|March 3, 2012
Factor seven activating protease activity levels in women with recurrent pregnancy lossSilvia Riondino, Patrizia Ferroni, Francesca La Farina, et al.
Pageof 14